Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany. Results from the prospective German Registry CRISP (AIO-TRK-0315) 18. Februar 2019 Griesinger, F., Eberhardt, W.E.E., Nusch, A., Reiser, M., Zahn, M.O., Marschner, N., Jaenicke, M., Fleitz, A., Spring, L., Sahlmann, J., Karatas, A., Hipper, A., Weichert, W., Rittmeyer, A., Christopoulos, P., Waller, C.F., Sebastian, M., Thomas, M., 2019. Pneumologie 2019; 73(S 01) DOI: 10.1055/s-0039-1678074